The Effect of Deep Neuromuscular Blockade With Sugammadex Reversal on Shoulder Pain of Elderly Patients Undergoing Robotic Surgery: A Single-Center Double-Blinded Randomized Controlled Trial
Status: Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 25 Nov 2019
Price : $35 *
At a glance
- Drugs Neostigmine (Primary) ; Sugammadex (Primary)
- Indications Neuromuscular blockade
- Focus Therapeutic Use
- 25 Nov 2019 Results (n=50) published in the British Journal of Anaesthesia.
- 05 Apr 2019 Status changed from recruiting to active, no longer recruiting.
- 14 Mar 2018 Planned End Date changed from 1 Nov 2019 to 1 Nov 2020.